National healthcare corp (NHC)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash Flows From Operating Activities:
Net income/(loss)

19,929

67,976

72,425

74,136

82,829

58,699

61,859

51,956

40,150

55,682

48,249

48,175

49,472

50,538

51,651

53,108

53,600

53,143

52,967

53,229

53,382

53,369

55,158

62,206

64,037

64,613

63,919

61,238

60,451

59,300

58,849

58,864

58,920

64,990

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

42,340

42,419

42,233

42,007

42,069

41,894

42,219

42,615

42,699

42,652

41,785

40,950

39,964

39,023

38,519

37,794

37,535

37,114

36,682

36,048

35,417

34,384

32,718

31,124

29,491

28,547

28,597

28,954

29,368

29,792

29,725

29,630

29,319

28,901

0

0

0

Provision for doubtful accounts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,883

6,615

6,487

6,583

6,701

6,870

6,706

6,228

7,896

6,825

5,923

5,226

3,013

2,836

2,760

2,455

2,514

2,538

2,428

2,430

0

0

0

Equity in earnings of unconsolidated investments

10,234

9,744

10,428

10,405

9,927

1,020

-836

-1,032

-1,180

6,932

7,618

6,896

6,657

6,636

6,847

6,579

6,231

5,845

5,530

5,407

5,881

6,675

7,715

10,247

12,295

14,188

15,079

15,195

14,618

13,616

12,550

10,952

10,397

9,674

0

0

0

Distributions from unconsolidated investments

6,220

3,902

5,295

4,109

3,018

5,241

3,911

7,233

7,474

7,829

8,644

6,761

7,817

8,059

7,180

7,391

6,405

6,505

6,504

5,786

7,922

10,288

10,289

14,745

18,768

15,473

15,472

11,902

8,323

6,317

12,897

12,280

10,021

10,828

0

0

0

Unrealized (gains)/losses on marketable equity securities

-55,000

12,230

16,817

10,991

23,493

1,138

417

-3,069

-15,517

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gains on sale of restricted marketable debt securities

129

127

117

-7

7

18

25

49

239

262

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on acquisition of equity method investment

3,682

1,975

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gains on sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

921

685

504

566

656

628

584

379

738

-173

-55

39

179

1,037

1,183

1,640

1,289

1,577

1,343

754

0

0

0

Deferred income taxes

12,559

-4,052

-5,838

-4,388

-7,527

-718

2,766

8,630

11,577

4,714

-4,819

-6,575

-4,971

-4,791

-4,534

-5,273

-4,419

-648

1,712

2,218

1,860

1,434

4,791

4,121

3,101

2,404

339

-619

-863

-1,416

-2,882

-678

-1,794

-2,577

0

0

0

Stock–based compensation

1,920

1,878

1,688

1,709

1,774

1,778

1,953

2,023

2,014

1,678

1,270

847

315

509

927

1,344

1,790

1,982

2,031

1,983

2,017

2,021

2,033

2,109

2,282

2,298

2,253

2,327

2,321

2,366

2,423

2,396

2,310

2,751

0

0

0

Restricted Cash and Cash Equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

7,717

6,425

3,995

10,405

10,087

9,818

9,925

7,636

6,073

7,812

5,082

7,830

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

-1,432

-4,299

4,777

14,109

14,504

9,398

5,896

2,590

1,667

4,236

-2,170

-1,383

-278

-1,564

1,683

5,886

6,649

11,835

15,138

3,985

6,982

5,215

7,141

16,529

14,919

13,778

15,433

11,695

6,026

7,263

-8

1,340

5,819

-5,032

0

0

0

Income tax receivable

0

2,560

127

0

-1,527

-5,465

-3,710

-2,447

1,527

800

1,707

1,532

0

1,462

3,593

915

0

-1,524

0

0

0

-

-

-

-

-5,933

-2,691

-2,691

-2,691

-537

0

0

0

-

-

-

-

Inventories

860

-29

184

11

-313

317

477

108

-54

-355

-333

61

22

-60

-120

-136

185

441

204

94

-147

-19

284

830

702

486

599

-445

-380

-759

-763

-845

-761

-434

0

0

0

Prepaid expenses and other assets

794

287

238

782

2,120

1,743

1,190

1,378

147

796

715

479

804

477

387

179

10

-89

2,110

2,348

1,672

2,587

-103

-251

60

76

289

112

138

77

-447

-153

-164

-169

0

0

0

Trade accounts payable

-1,823

-856

-918

-743

2,289

3,467

4,561

1,428

-1,864

-2,615

-2,623

-7,065

688

-1,535

1,252

4,682

-2,825

4,251

2,500

184

2,743

2,827

1,085

5,686

7,025

2,495

7,086

5,083

840

831

-3,903

-5,569

-881

-1,113

0

0

0

Accrued payroll

2,595

2,208

1,010

1,003

1,405

516

2,901

2,377

2,507

1,190

5,007

3,306

-8,738

574

-8,705

995

5,041

5,479

4,861

5,639

4,994

-3,603

-2,222

4,172

5,294

26,219

6,370

178

-2,033

-16,418

1,282

1,626

2,445

2,008

0

0

0

Amounts due to third party payors

-832

-1,000

-1,685

-419

-862

-1,281

-3,053

-732

-532

370

1,642

-460

89

365

-7,404

-7,047

-6,835

-6,277

2,299

2,549

1,925

1,312

3,103

2,154

3,416

2,352

-15

2,093

-165

481

708

-1,024

357

-860

0

0

0

Accrued risk reserves

2,665

540

2,391

2,507

2,345

2,818

1,363

1,229

2,380

3,070

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities

-4,013

780

6,033

3,417

7,990

-2,050

-3,837

161

-3,590

2,987

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities and accrued risk reserves

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-9,413

-

-5,742

-3,164

-5,068

-5,652

-9,299

-3,006

-5,085

-6,401

13,702

3,865

16,112

11,675

6,825

9,197

-5,949

-9,129

0

0

0

Other noncurrent liabilities

-716

854

-938

-940

-826

-591

-839

-1,015

-698

-507

-668

-17

42

8

-527

-30

-27

283

1,106

1,646

1,644

1,486

1,605

707

709

635

450

-1,543

-1,642

-2,354

-3,378

-2,316

-2,792

-2,617

0

0

0

Deferred revenue

-66

82

-73

-241

-184

-172

-115

-265

-338

-136

-145

181

121

47

23

-187

81

-44

50

42

-303

39

102

-63

-639

-110

-410

-475

-243

-91

-400

-447

-378

-206

0

0

0

Net cash provided by operating activities

96,256

100,103

96,253

88,234

96,730

98,435

100,537

103,534

94,761

94,466

97,096

84,759

79,643

90,882

84,806

89,607

83,224

83,355

87,323

95,120

91,172

81,939

70,130

82,264

92,648

102,348

93,208

80,177

85,675

64,373

89,913

86,475

74,510

82,358

0

0

0

Cash Flows From Investing Activities:
Additions to property and equipment

27,154

26,400

26,734

28,305

28,546

29,772

30,727

31,122

31,381

32,347

36,463

43,155

57,235

62,601

69,929

71,497

59,268

58,416

55,524

53,381

56,607

53,298

46,184

46,305

46,343

43,438

41,096

35,857

25,397

22,003

20,379

16,262

20,184

23,372

0

0

0

Acquisition of equity method investment, net of cash acquired

22,237

15,589

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investments in notes receivable

5,400

5,462

0

0

0

-

-

-

-

-

-

-

-

5,251

2,618

3,583

7,478

5,676

5,477

4,237

42

767

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Investments in unconsolidated companies

222

222

0

0

0

-

-

-

-

246

176

554

554

1,282

1,583

1,255

1,255

674

673

986

1,592

1,975

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Collections of notes receivable

1,402

1,379

1,383

1,413

1,475

1,553

1,492

1,431

1,795

4,282

4,761

4,859

4,477

1,636

5,460

5,148

4,911

4,948

443

447

3,238

3,156

1,098

14,224

11,503

11,865

14,737

1,818

1,484

1,260

-15

103

1,040

1,222

0

0

0

Change in restricted cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-6,160

-5,763

-4,208

-8,039

-33,855

-48,230

-45,735

-46,660

-19,274

-5,074

-11,515

-9,235

0

0

0

Purchase of restricted marketable debt securities

15,266

12,471

14,548

13,653

14,182

13,311

16,320

15,014

31,647

31,244

38,747

47,543

39,832

48,620

45,294

48,440

63,202

60,540

75,211

67,944

49,200

62,165

61,124

80,447

92,344

93,155

114,891

118,344

109,541

111,691

75,142

63,802

69,720

57,597

0

0

0

Sale of restricted marketable debt securities

41,334

44,500

41,272

30,243

7,580

4,539

8,138

9,840

19,845

50,197

50,277

53,701

52,956

34,642

38,936

44,975

47,739

47,574

60,746

49,441

39,741

48,786

51,126

70,880

83,787

81,389

77,949

66,928

61,310

62,649

53,012

56,605

56,090

46,266

0

0

0

Net cash used in investing activities

-27,543

-14,265

-16,395

-28,230

-30,781

-33,662

-37,840

-35,137

-41,660

-9,560

-23,180

-35,799

-43,595

-81,476

-82,451

-80,390

-70,535

-72,784

-74,529

-71,286

-68,729

-67,031

-52,134

-59,732

-61,662

-56,300

-51,046

-37,825

-34,509

-31,225

-38,250

-33,282

-28,759

-31,746

0

0

0

Cash Flows From Financing Activities:
Borrowings under credit facility

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments under finance lease obligations

3,983

3,923

3,865

3,808

3,752

3,696

3,641

3,586

3,533

3,481

3,429

3,379

3,328

3,278

3,230

3,182

3,135

3,089

3,042

2,997

2,953

2,436

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Dividends paid to common stockholders

31,553

31,208

30,853

30,500

30,153

29,827

29,508

29,190

28,716

28,237

27,761

27,343

26,618

25,795

24,699

23,523

22,292

21,089

20,158

19,293

19,000

18,704

18,409

18,072

17,729

17,469

31,286

30,976

30,939

30,849

16,678

16,632

16,294

15,952

0

0

0

Dividends paid to preferred stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,986

8,670

8,670

8,670

8,670

8,670

8,670

8,671

8,671

8,671

8,671

8,671

8,671

8,671

8,671

8,671

8,671

0

0

0

Issuance of common shares

2,167

2,346

2,921

2,921

2,377

2,865

2,224

2,355

2,774

2,524

2,329

2,198

2,259

10,772

12,473

14,961

14,928

10,634

8,903

6,420

5,989

7,429

0

0

0

-

-

-

-

13,412

7,200

6,823

8,017

8,392

0

0

0

Repurchase of common shares

53

872

872

872

872

867

867

867

867

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

4,700

0

0

0

-

-

-

-

-

-

-

-

Equity contributed by noncontrolling entities

0

-

-

-

0

-

-

-

-

1,217

0

0

970

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tax expense from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,096

223

466

538

1,942

585

342

311

201

0

0

0

-

-

-

-

-267

363

202

-250

52

0

0

0

Entrance fee refunds

-

-

-

-

-

-749

-159

-499

-737

-1,097

0

0

0

-

-

-185

-88

-354

-112

-662

-1,028

-501

-280

38

350

40

-179

-560

-642

-1,310

-1,572

-2,045

-2,113

-1,704

0

0

0

Change in deposits

-

-

-

-

-

-

-

-

-

-

-

-232

-389

402

173

128

93

406

286

485

699

-448

-1,121

-1,418

-1,750

-1,010

-124

103

347

230

233

101

-24

-95

0

0

0

Net cash provided by (used in) financing activities

-39,232

-79,748

-79,509

-62,969

-77,990

-77,274

-76,704

-66,122

-50,170

-49,074

-28,546

-36,607

-35,877

-27,131

-47,417

-37,125

-37,913

-41,675

-22,208

-31,370

-31,647

-30,124

-29,489

-21,408

-20,688

-31,044

-37,459

-36,927

-37,041

-27,455

-21,114

-21,315

-19,541

-18,082

0

0

0

Net Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents

29,481

6,090

349

-2,965

-12,041

-12,501

-14,007

2,275

2,931

35,832

45,370

12,353

171

-17,725

-45,062

-27,908

-25,224

-31,104

-9,414

-7,536

-9,204

-15,216

-11,493

1,124

10,298

15,004

4,703

5,425

14,125

5,693

30,549

31,878

26,210

32,530

0

0

0

Non-cash financing and investing activities include:
Buildings, personal property, and obligations recorded under capital lease agreements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

39,032

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-